A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
PHASE3
The goal of this study is to evaluate the efficacy and safety of pembrolizu...
Status
Active Not Recruiting
Location
The University of Alabama at Birmingham ( Site 0010)
A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)
PHASE3
The purpose of this study is to assess the efficacy and safety of oral belz...
Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients
NA
Study in which a zinc oxide fixation device (a product that can help protec...
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study
PHASE3
The goal of this China extension study is to evaluate the efficacy and safe...
Status
Active Not Recruiting
Location
Beijing Cancer hospital-Renal carcinoma and melanoma ( Site 6000)